- Home
- BNTX vs BR Comparison
BNTX vs BR Comparison
Compare BNTX & BR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | BR |
|---|---|---|
| Founded | 2008 | 1962 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 26.6B |
| IPO Year | 2019 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BNTX | BR |
|---|---|---|
| Price | $95.02 | $223.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $137.40 | ★ $259.83 |
| AVG Volume (30 Days) | ★ 1.5M | 660.7K |
| Earning Date | 11-03-2025 | 01-30-2026 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | N/A | ★ 35.12 |
| EPS | N/A | ★ 7.82 |
| Revenue | $3,698,814,972.00 | ★ $7,055,600,000.00 |
| Revenue This Year | $2.03 | $8.71 |
| Revenue Next Year | N/A | $4.75 |
| P/E Ratio | ★ N/A | $28.81 |
| Revenue Growth | 3.70 | ★ 8.57 |
| 52 Week Low | $81.20 | $212.33 |
| 52 Week High | $129.27 | $271.91 |
Technical Indicators
Market Signals| Indicator | BNTX | BR |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 39.12 |
| Support Level | $94.00 | $226.30 |
| Resistance Level | $95.71 | $229.77 |
| Average True Range (ATR) | 1.74 | 3.16 |
| MACD | 0.52 | -0.45 |
| Stochastic Oscillator | 62.66 | 0.00 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.